Coherus BioSciences Inc (NASDAQ:CHRS)
| 4.36 Delayed Data As of May 26 |  +0.06 / +1.40%Today’s Change | 4.16 Today|||52-Week Range 14.11 | -45.01% Year-to-Date |
Latest CHRS News | Press Releases
No recent news for Coherus BioSciences Inc.
Today’s Trading
| Previous close | 4.29 |
| Today’s open | 4.40 |
| Day’s range | 4.25 - 4.52 |
| Volume | 2,449,122 |
| Average volume (3 months) | 1,383,896 |
| Market cap | $409.4M |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | +1.23% |
| Earnings growth (this year) | +44.96% |
| Earnings growth (next 5 years) | +92.47% |
| Revenue growth (last year) | -35.37% |
| P/E ratio | NM |
| Price/Sales | 2.91 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EBSEmergent BioSolution... | +0.02 | +0.25% |
| SIGASIGA Technologies In... | +0.07 | +1.25% |
| MGTXMeiraGTx Holdings PL... | +0.28 | +4.37% |
| CLLKFBICO Group AB | 0.00 | 0.00% |
Data as of 3:59pm ET, 05/26/2023
Financials
| Next reporting date | August 3, 2023 |
| EPS forecast (this quarter) | -$0.72 |
| Annual revenue (last year) | $211.0M |
| Annual profit (last year) | -$291.8M |
| Net profit margin | -138.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
